vs
Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and N-able, Inc. (NABL). Click either name above to swap in a different company.
N-able, Inc. is the larger business by last-quarter revenue ($130.3M vs $85.1M, roughly 1.5× 4D Molecular Therapeutics, Inc.). On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 11.8%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $20.9M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 7.0%).
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
Able UK is a British industrial services company specialising in decommissioning of ships and offshore installations.
FDMT vs NABL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $85.1M | $130.3M |
| Net Profit | $19.4M | — |
| Gross Margin | — | 76.2% |
| Operating Margin | 17.3% | 10.2% |
| Net Margin | 22.8% | — |
| Revenue YoY | 8508900.0% | 11.8% |
| Net Profit YoY | 139.1% | — |
| EPS (diluted) | $0.43 | $-0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $85.1M | $130.3M | ||
| Q3 25 | $90.0K | $131.7M | ||
| Q2 25 | $15.0K | $131.2M | ||
| Q1 25 | $14.0K | $118.2M | ||
| Q4 24 | $1.0K | $116.5M | ||
| Q3 24 | $3.0K | $116.4M | ||
| Q2 24 | $5.0K | $119.4M | ||
| Q1 24 | $28.0K | $113.7M |
| Q4 25 | $19.4M | — | ||
| Q3 25 | $-56.9M | $1.4M | ||
| Q2 25 | $-54.7M | $-4.0M | ||
| Q1 25 | $-48.0M | $-7.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-43.8M | $10.8M | ||
| Q2 24 | $-35.0M | $9.5M | ||
| Q1 24 | $-32.4M | $7.5M |
| Q4 25 | — | 76.2% | ||
| Q3 25 | — | 77.5% | ||
| Q2 25 | — | 78.1% | ||
| Q1 25 | — | 76.6% | ||
| Q4 24 | — | 80.0% | ||
| Q3 24 | — | 82.9% | ||
| Q2 24 | — | 84.0% | ||
| Q1 24 | — | 83.9% |
| Q4 25 | 17.3% | 10.2% | ||
| Q3 25 | -67983.3% | 8.8% | ||
| Q2 25 | -396373.3% | 7.7% | ||
| Q1 25 | -383007.1% | 1.5% | ||
| Q4 24 | — | 13.7% | ||
| Q3 24 | -1704400.0% | 20.5% | ||
| Q2 24 | -849120.0% | 18.4% | ||
| Q1 24 | -136200.0% | 18.0% |
| Q4 25 | 22.8% | — | ||
| Q3 25 | -63195.6% | 1.1% | ||
| Q2 25 | -364386.7% | -3.1% | ||
| Q1 25 | -342657.1% | -6.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | -1461433.3% | 9.2% | ||
| Q2 24 | -699060.0% | 7.9% | ||
| Q1 24 | -115717.9% | 6.6% |
| Q4 25 | $0.43 | $-0.04 | ||
| Q3 25 | $-1.01 | $0.01 | ||
| Q2 25 | $-0.98 | $-0.02 | ||
| Q1 25 | $-0.86 | $-0.04 | ||
| Q4 24 | — | $0.01 | ||
| Q3 24 | $-0.79 | $0.06 | ||
| Q2 24 | $-0.63 | $0.05 | ||
| Q1 24 | $-0.66 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $402.7M | $111.8M |
| Total DebtLower is stronger | — | $393.9M |
| Stockholders' EquityBook value | $505.7M | $804.7M |
| Total Assets | $566.7M | $1.4B |
| Debt / EquityLower = less leverage | — | 0.49× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $402.7M | $111.8M | ||
| Q3 25 | $305.1M | $101.4M | ||
| Q2 25 | $293.2M | $93.9M | ||
| Q1 25 | $321.4M | $94.1M | ||
| Q4 24 | $424.9M | $85.2M | ||
| Q3 24 | $501.9M | $174.4M | ||
| Q2 24 | $541.9M | $157.5M | ||
| Q1 24 | $525.9M | $139.2M |
| Q4 25 | — | $393.9M | ||
| Q3 25 | — | $331.7M | ||
| Q2 25 | — | $332.1M | ||
| Q1 25 | — | $332.6M | ||
| Q4 24 | — | $333.1M | ||
| Q3 24 | — | $333.6M | ||
| Q2 24 | — | $334.1M | ||
| Q1 24 | — | $334.5M |
| Q4 25 | $505.7M | $804.7M | ||
| Q3 25 | $369.0M | $813.4M | ||
| Q2 25 | $420.9M | $809.4M | ||
| Q1 25 | $469.7M | $775.1M | ||
| Q4 24 | $510.6M | $759.3M | ||
| Q3 24 | $552.9M | $765.0M | ||
| Q2 24 | $588.3M | $724.4M | ||
| Q1 24 | $600.6M | $709.1M |
| Q4 25 | $566.7M | $1.4B | ||
| Q3 25 | $424.0M | $1.4B | ||
| Q2 25 | $473.6M | $1.4B | ||
| Q1 25 | $515.7M | $1.4B | ||
| Q4 24 | $560.4M | $1.3B | ||
| Q3 24 | $604.0M | $1.2B | ||
| Q2 24 | $620.1M | $1.2B | ||
| Q1 24 | $629.9M | $1.1B |
| Q4 25 | — | 0.49× | ||
| Q3 25 | — | 0.41× | ||
| Q2 25 | — | 0.41× | ||
| Q1 25 | — | 0.43× | ||
| Q4 24 | — | 0.44× | ||
| Q3 24 | — | 0.44× | ||
| Q2 24 | — | 0.46× | ||
| Q1 24 | — | 0.47× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.6M | $25.3M |
| Free Cash FlowOCF − Capex | $28.5M | $20.9M |
| FCF MarginFCF / Revenue | 33.5% | 16.0% |
| Capex IntensityCapex / Revenue | 0.1% | 3.4% |
| Cash ConversionOCF / Net Profit | 1.47× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-109.9M | $75.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.6M | $25.3M | ||
| Q3 25 | $-46.5M | $24.0M | ||
| Q2 25 | $-43.4M | $24.2M | ||
| Q1 25 | $-47.8M | $19.7M | ||
| Q4 24 | $-134.6M | $26.0M | ||
| Q3 24 | $-29.4M | $22.0M | ||
| Q2 24 | $-30.2M | $27.3M | ||
| Q1 24 | $-29.1M | $4.2M |
| Q4 25 | $28.5M | $20.9M | ||
| Q3 25 | $-46.6M | $17.4M | ||
| Q2 25 | $-43.4M | $20.4M | ||
| Q1 25 | $-48.4M | $16.4M | ||
| Q4 24 | $-138.4M | $18.8M | ||
| Q3 24 | $-31.2M | $18.2M | ||
| Q2 24 | $-30.6M | $24.0M | ||
| Q1 24 | $-29.8M | $746.0K |
| Q4 25 | 33.5% | 16.0% | ||
| Q3 25 | -51765.6% | 13.2% | ||
| Q2 25 | -289620.0% | 15.5% | ||
| Q1 25 | -345635.7% | 13.9% | ||
| Q4 24 | -13837100.0% | 16.2% | ||
| Q3 24 | -1038966.7% | 15.7% | ||
| Q2 24 | -611840.0% | 20.1% | ||
| Q1 24 | -106421.4% | 0.7% |
| Q4 25 | 0.1% | 3.4% | ||
| Q3 25 | 101.1% | 5.0% | ||
| Q2 25 | 440.0% | 2.9% | ||
| Q1 25 | 4507.1% | 2.8% | ||
| Q4 24 | 378600.0% | 6.1% | ||
| Q3 24 | 59266.7% | 3.2% | ||
| Q2 24 | 6980.0% | 2.7% | ||
| Q1 24 | 2535.7% | 3.0% |
| Q4 25 | 1.47× | — | ||
| Q3 25 | — | 17.36× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.04× | ||
| Q2 24 | — | 2.89× | ||
| Q1 24 | — | 0.56× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FDMT
Segment breakdown not available.
NABL
| Transferred Over Time | $121.9M | 94% |
| Transferred At Point In Time | $8.4M | 6% |
| Other Revenue | $1.3M | 1% |
